📰 Free Newsletter – https://bit.ly/3VEn9vu
🧢 CLN Merch
https://spreadshop-admin.spreadshirt.com/Legalization-News-merch/all
🤝 Work With Us
https://bit.ly/m/collateral-base
💰 Sponsor the Show
cannabislegalizationnews.com/sponsor

👍 Like • 🔔 Subscribe • 💬 Comment:

Blog Link: https://cannabisindustrylawyer.com/when-will-cannabis-be-schedule-iii/

In this episode of Cannabis Legalization News, we dive deep into the complexities of rescheduling cannabis to Schedule III under U.S. federal law. We'll break down the steps, key statutes, and timelines involved while discussing the delays and bureaucratic hurdles currently stalling the process. Learn about the Congressional Review Act, federal regulations, and the potential impact of recent legal proceedings, including Trump's executive orders and the involvement of former Attorney General Bill Barr. Stay informed with our detailed examination and keep up with the latest developments in cannabis legalization.

00:00 Introduction and Overview
00:06 Current Status of Schedule Three Cannabis
02:03 Legal Procedures and Statutes
03:28 Steps to Reschedule Cannabis
04:30 Interlocutory Appeal and Hearing
06:45 Post-Hearing Procedures
09:49 Congressional Review Act (CRA)
11:47 Judicial Review and Final Thoughts
13:40 Conclusion and Viewer Interaction

467 116

Is a "CBD Purchasing Mandate" the answer to stabilizing the hemp market? 🏛️📊
By imposing specific CBD-to-THC ratios, the federal government could inadvertently create a massive surge in demand for hemp-derived CBD.
The Multiplier Effect:
If a beverage contains 5mg of THC, a mandated 20:1 ratio would force the inclusion of 100mg of CBD. That moves a single unit from 5mg of total cannabinoids to 105mg—a staggering 21x increase.
This shift would transform the THC market into a "CBD purchasing mandate," providing a significant boost to the agricultural commodity industry and hemp farmers nationwide. 🚜🌱
The Big Question:
Would people buy them? Or are people just buying THC for its effects?
I’d love to hear from my network in the #Cannabis and #Hemp sectors. How would your supply chain handle an 8x or 21x increase in CBD demand? 💬
#HempRegulation #CBDMarket #CannabisBusiness #AgriculturalPolicy #SupplyChain #MarketTrends #FarmBill2024

151 11

📰 Free Newsletter – https://bit.ly/3VEn9vu
🧢 CLN Merch
https://spreadshop-admin.spreadshirt.com/Legalization-News-merch/all
🤝 Work With Us
https://bit.ly/m/collateral-base
💰 Sponsor the Show
cannabislegalizationnews.com/sponsor

👍 Like • 🔔 Subscribe • 💬 Comment:

This episode of Cannabis Legalization News, hosted by cannabis lawyer Tom, explores the potential impact of a federal regulatory framework imposing CBD-to-THC ratios on hemp products. Tom explains how a 20:1 CBD to THC ratio, as proposed in Trump's executive order, could lead to a massive increase in cannabinoid demand, effectively benefiting hemp farmers. By enforcing this ratio, products that currently sell for their THC content would have to include significantly higher amounts of CBD, potentially revitalizing the depressed CBD commodity market. The episode delves into the math behind this potential regulation, illustrating how it could multiply cannabinoid demand per unit sold and ultimately alter the hemp market, making it more sustainable and profitable for farmers.

00:00 Introduction to Cannabis Legalization News
00:37 The 2018 Hemp Legalization and Its Implications
01:41 Understanding the Proposed THC to CBD Ratio
02:50 Impact of Ratio Rules on Hemp Beverages
04:38 Scaling Up: Market Demand and Economic Implications
08:46 The Future of Hemp: Edibles and Beyond
10:15 Conclusion and Call to Action

444 159

🚨 SCHEDULE 3 DELAYED? DOJ is swamped (Epstein files + Maduro trial + SCOTUS pressure). What does this mean for marijuana rescheduling?

🔗 Join the Movement
Free Newsletter – https://bit.ly/3VEn9vu

🧢 CLN Merch
https://spreadshop-admin.spreadshirt.com/Legalization-News-merch/all

🤝 Work With Us
https://bit.ly/m/collateral-base

💰 Sponsor the Show
cannabislegalizationnews.com/sponsor

📌 Full article + sources on our site: https://cannabislegalizationnews.com/schedule-3-delayed-doj-backlog/
👍 Like • 🔔 Subscribe • 💬 Comment: “Delay or still on track?”

#Cannabis #ScheduleIII #DOJ #MarijuanaRescheduling #CannabisNews

want to start your own podcast? Try StreamYard.
Want to create live streams like this? Check out StreamYard: https://streamyard.com/pal/d/5822037327085568

275 95

0:00-0:03 (The Hook): [Tom pointing at the camera with big text overlay: "NO MORE 280E?"] "Licensed operators, your biggest tax prize is landing in Q1 of 2026."
0:03-0:15 (The Meat): "My top prediction: Rescheduling to Schedule III officially crosses the finish line before March ends. Why does that matter? It kills 280E."
0:15-0:30 (The Agitation): "No more paying taxes on your gross profit. You can finally deduct marketing, rent, and normal business expenses like any other industry."
0:30-0:45 (The Call to Action): "But don’t wait for the IRS to send a check—you need a restructuring strategy now. Watch my full 2026 forecast for the deadlines you can’t miss. Link in the pinned comment!"
We predict what's next for cannabis, considering the potential impact of Schedule 3 and the critical role of "irc 280e". This episode also explores the implications of the hemp fix and FDA regulations on "cbd regulation" and "hemp cannabinoids". We also discuss the significance of research and Medicare CBD in the evolving "cannabis business" and "cannabis regulations" landscape. Stay informed with the latest "cannabis news"!

392 37

2026 Cannabis Legalization Predictions: Rescheduling, Hemp Laws, and CBD Research. We predict what's next for cannabis, considering the potential impact of Schedule 3 and the critical role of "irc 280e". This episode also explores the implications of the hemp fix and FDA regulations on "cbd regulation" and "hemp cannabinoids". We also discuss the significance of research and Medicare CBD in the evolving "cannabis business" and "cannabis regulations" landscape. Stay informed with the latest "cannabis news"!

In this episode, Tom, a cannabis lawyer, shares his predictions for cannabis legalization in 2026, focusing on three key areas: 1. When marijuana could be rescheduled to Schedule III and the tax benefits for businesses; 2. Potential changes to hemp laws that may impact the market; 3. The importance of CBD research and Medicare coverage. Tom provides a detailed analysis of the legislative and regulatory timelines, emphasizing the complexities and bureaucratic hurdles involved. He also highlights the significance of accurate data and research for the future of cannabis in healthcare.

We predict what's next for cannabis legalization in 2026, focusing on potential marijuana rescheduling and how it impacts the industry. This episode also explores the "hemp fix" and the role of research and Medicare CBD, especially for cannabis for seniors. Stay informed on these critical cannabis news and market trends.

00:00 Introduction and 2026 Predictions Overview
00:28 Understanding Schedule Three and 280E
00:50 Debunking Common Misconceptions
01:37 Rescheduling Timeline and Industry Impact
02:43 Hemp Legislation and Enforcement
03:37 Congressional Actions and Deadlines
04:35 FDA's Role and New Hemp Definitions
06:51 Executive Orders and Regulatory Framework
12:58 Research and Medical Use of Cannabinoids
15:12 Predictions for 2026
16:34 Conclusion and Call to Action

2.2K 478

America's Worst Drug Policy: It's Not What You Think

In this eye-opening episode, we dive into one of America's biggest policy failures: the pricing of prescription medications like GLP-1s. While many focus on the legalization and rescheduling of cannabis, there's a far more insidious, legal, and mainstream drug policy draining your paycheck and costing countless lives. We break down the economics, the hidden players like PBMs, and the stark differences in drug pricing between the US and other countries. Learn how we can fix this broken system and why it matters for your wallet and your health. 💊💸 #DrugPolicy #HealthcareCosts #Cannabis #DrugPrices #GLP1 #EconomicImpact 🌿💰

00:00 Introduction: The Real Worst Drug Policy in America
01:23 Cannabis: The Obvious Candidate
04:30 The Hidden Cost of GLP-1 Medications
06:30 The Economics of GLP-1 Pricing
08:15 Global Comparison and Policy Solutions
14:01 Conclusion: The Real Crime in Drug Policy

In this eye-opening episode, we discuss a mainstream, legal drug policy that is quietly draining more money from your paycheck than the war on drugs. We break down the economics and the hidden players like pharmacy benefit managers (PBMs) that impact your "prescription benefits". Learn how this system impacts your wallet and how to make money moves to protect yourself from these rising "prescription" costs through understanding the role of your "pharmacy" and big "pharmacy benefit manager" companies.

510 103

385 30

One day soon, Trump will be calling the move to reschedule cannabis a "historic victory"—but is it all just a masterclass in political grandstanding? 🏛️
While some celebrate, others are screaming "trap" by Big Pharma. Is this a real step toward freedom, or just a 2024 election "sleight of hand"? 🃏✨
We’re breaking down the Schedule 1 to Schedule 3 shuffle and what it actually means for you and the future of the herb. 🇺🇸
Watch the full breakdown now!
👇 Let’s settle this in the comments:
Is this a genuine victory for the cannabis community, or just another political game?
#CannabisReform #Schedule3 #Trump #Biden #BigPharma #MarijuanaFreedom #CannabisCommunity #PoliticsToday #LegalizeIt

232 60